NEPA, a fixed-dose combination of netupitant and palonosetron, prevents chemotherapy-induced nausea and vomiting (CINV) more effectively and reduces the impact on daily living for breast cancer patients compared with palonosetron

Rugo, H.S. and Rossi, G. and Rizzi, G. and Borroni, M.E. and Lorusso, V. and Kapthaus, M. and Bondarenko, I. and Sarosiek, T.J. and Aapro, M.S. (2013) NEPA, a fixed-dose combination of netupitant and palonosetron, prevents chemotherapy-induced nausea and vomiting (CINV) more effectively and reduces the impact on daily living for breast cancer patients compared with palonosetron. American Association for Cancer Research, 73 (Sup.24).

Text Abstract2013,36.pdf Download (34kB)

Abstract

Abstract nr P3-09-01

Item Type:	Article
Subjects:	Oncology
Divisions:	Departments > Department of Oncology and Medical Radiology
Depositing User:	Елена Шрамко
Date Deposited:	26 Sep 2016 10:38
Last Modified:	26 Sep 2016 10:40
URI:	http://repo.dma.dp.ua/id/eprint/964

Actions (login required)

View Item